ciprofloxacin has been researched along with daptomycin in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (14.81) | 18.7374 |
| 1990's | 2 (7.41) | 18.2507 |
| 2000's | 4 (14.81) | 29.6817 |
| 2010's | 15 (55.56) | 24.3611 |
| 2020's | 2 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Lentino, JR; Strodthman, R | 1 |
| Chandrasekar, PH; Sluchak, JA | 1 |
| Liu, C; Stratton, CW; Weeks, LS | 1 |
| Liu, C; Ratner, HB; Stratton, CW; Weeks, LS | 1 |
| Landman, D; Mobarakai, N; Quale, JM | 1 |
| Garcia, R; Raad, I | 1 |
| D'Costa, VM; Hughes, DW; McGrann, KM; Wright, GD | 1 |
| Appleman, MD; Citron, DM | 1 |
| Alder, JD; Mascio, CT; Silverman, JA | 1 |
| Ghosh, M; Gilliam, BL; Talwani, R | 1 |
| Bossaer, JB; Garrett-Mayer, E; Hall, PD | 1 |
| Fajardo, M; Garduno, E; Hidalgo, R; Robles, M; Rodríguez, FF; Rodríguez, S | 1 |
| Bassett, J; Byrne, WR; Heine, HS; Miller, L; Purcell, BK | 1 |
| Fajardo Olivares, M; Hidalgo Orozco, R; Robles Marcos, M; Rodríguez Garrido, S; Rodríguez-Vidigal, FF; Vera Tomé, A | 1 |
| Bertram, R; Klumpp, S; Lechner, S; Patra, P | 1 |
| Bertram, R; Götz, F; Leibig, M; Ohlsen, K; Schäfer, T; Yu, W | 1 |
| Drew, RJ; Paulus, S | 1 |
| Cars, O; Forsberg, P; Giske, CG; Hickman, RA; Lagerbäck, P; Tängdén, T | 1 |
| Buyck, JM; Peyrusson, F; Tulkens, PM; Van Bambeke, F | 1 |
| Blaskovich, MA; Butler, MS; Cooper, MA; Elliott, AG; Huang, JX; Kavanagh, A; Montgomery, AB; Pelingon, R; Ramu, S | 1 |
| Akcaer, M; Coskun, O; Karakas, A; Sari, S; Tok, D | 1 |
| Desai, S; Nair, S; Poonacha, N; Sharma, U; Vipra, A | 1 |
| Chen, J; Drlica, K; Kumar, K; Shopsin, B | 1 |
| Holzknecht, BJ; Justesen, US; Lund, LC | 1 |
| El-Najjar, N; Gessner, A; Hösl, J | 1 |
| Goto, K; Itoh, H; Kai, M; Kitano, T; Ohchi, Y; Suzuki, Y; Tanaka, R; Tatsuta, R; Yasuda, N | 1 |
| Grinholc, M; Kruszewska, B; Pierański, MK; Rychłowski, M; Woźniak, A | 1 |
1 review(s) available for ciprofloxacin and daptomycin
| Article | Year |
|---|---|
[Treatment of vancomycin-resistant enterococcal infections].
Topics: Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Daptomycin; Denmark; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Linezolid; Nitrofurantoin; Tigecycline; Urinary Tract Infections; Vancomycin-Resistant Enterococci | 2018 |
26 other study(ies) available for ciprofloxacin and daptomycin
| Article | Year |
|---|---|
Comparison of in vitro activity of daptomycin, vancomycin and fluoroquinolones in broth and serum against Staphylococcus epidermidis as determined by time-kill kinetics.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Daptomycin; Fluoroquinolones; Kinetics; Microbial Sensitivity Tests; Peptides; Staphylococcus epidermidis; Vancomycin | 1989 |
Newer agents against methicillin and/or gentamicin-resistant and -susceptible staphylococci.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Drug Resistance, Microbial; Fluoroquinolones; Gentamicins; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Peptides; Species Specificity; Staphylococcus aureus | 1989 |
Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.
Topics: Anti-Bacterial Agents; Cefamandole; Cefazolin; Cefuroxime; Ciprofloxacin; Culture Media; Daptomycin; Kinetics; Methicillin; Microbial Sensitivity Tests; Peptides; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1987 |
Bactericidal activity of deptomycin (LY146032) compared with those of ciprofloxacin, vancomycin, and ampicillin against enterococci as determined by kill-kinetic studies.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Peptides; Vancomycin | 1987 |
Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Depsipeptides; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Peptides, Cyclic; Vancomycin | 1994 |
In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Bacteremia; Catheterization, Central Venous; Cefamandole; Cephalosporins; Ciprofloxacin; Clindamycin; Daptomycin; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Neoplasms; Novobiocin; Oxacillin; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin; Virginiamycin | 1996 |
Sampling the antibiotic resistome.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Genes, Bacterial; Ketolides; Macrolides; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Rifampin; Soil Microbiology; Streptomyces; Trimethoprim Resistance; Vancomycin Resistance; Virginiamycin | 2006 |
In vitro activities of daptomycin, ciprofloxacin, and other antimicrobial agents against the cells and spores of clinical isolates of Bacillus species.
Topics: Anti-Bacterial Agents; Bacillus; Ciprofloxacin; Daptomycin; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Spores, Bacterial | 2006 |
Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells.
Topics: Anti-Bacterial Agents; Cell Division; Ciprofloxacin; Daptomycin; Erythromycin; Gentamicins; Hydrazones; Microbial Sensitivity Tests; Nafcillin; Staphylococcus aureus; Vancomycin | 2007 |
Propionibacterium skull osteomyelitis treated with daptomycin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Gram-Positive Bacterial Infections; Humans; Male; Meningioma; Neurosurgical Procedures; Osteomyelitis; Propionibacterium acnes; Skull; Sphenoid Sinus; Surgical Flaps; Surgical Wound Infection; Young Adult | 2009 |
Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Ciprofloxacin; Daptomycin; Enterococcus; Female; Fever; Humans; Incidence; Linezolid; Male; Middle Aged; Neutropenia; Oxazolidinones; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2010 |
[Activity of daptomycin, ciprofloxacin, clindamycin and cotrimoxazole against coagulase-negative Staphylococcus strains with diminished susceptibility to vancomycin].
Topics: Ciprofloxacin; Clindamycin; Coagulase; Daptomycin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin Resistance | 2010 |
Efficacy of Daptomycin against Bacillus anthracis in a murine model of anthrax spore inhalation.
Topics: Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Ciprofloxacin; Daptomycin; Female; Mice; Mice, Inbred BALB C; Spores, Bacterial | 2010 |
Activity of vancomycin, ciprofloxacin, daptomycin, and linezolid against coagulase-negative staphylococci bacteremia.
Topics: Acetamides; Bacteremia; Catheter-Related Infections; Ciprofloxacin; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Hospital Departments; Hospitals, University; Humans; Length of Stay; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Spain; Staphylococcal Infections; Staphylococcus epidermidis; Staphylococcus haemolyticus; Staphylococcus hominis; Vancomycin | 2011 |
Interplay between population dynamics and drug tolerance of Staphylococcus aureus persister cells.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Daptomycin; Drug Tolerance; Microbial Viability; Models, Theoretical; Population Dynamics; Staphylococcus aureus; Tobramycin | 2012 |
The mevalonate auxotrophic mutant of Staphylococcus aureus can adapt to mevalonate depletion.
Topics: Adaptation, Physiological; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Colony Count, Microbial; Daptomycin; Gene Deletion; Genetic Complementation Test; Gentamicins; Ligases; Mevalonic Acid; Microbial Sensitivity Tests; Polyisoprenyl Phosphates; Rifampin; Staphylococcus aureus | 2013 |
Comparison of Sensititre microdilution method to other standard methods for susceptibility testing of coagulase-negative staphylococci from paediatric blood cultures.
Topics: Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clindamycin; Daptomycin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Oxacillin; Staphylococcus epidermidis; Staphylococcus hominis; Tetracycline; Vancomycin | 2014 |
Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Ciprofloxacin; Colistin; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fosfomycin; In Vitro Techniques; Klebsiella pneumoniae; Lipoglycopeptides; Meropenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Thienamycins; Tigecycline; Vancomycin | 2014 |
RX-P873, a Novel Protein Synthesis Inhibitor, Accumulates in Human THP-1 Monocytes and Is Active against Intracellular Infections by Gram-Positive (Staphylococcus aureus) and Gram-Negative (Pseudomonas aeruginosa) Bacteria.
Topics: Anti-Bacterial Agents; Ceftazidime; Cells, Cultured; Ciprofloxacin; Daptomycin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Guanidines; Humans; Microbial Sensitivity Tests; Monocytes; Moxifloxacin; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrimidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2015 |
Mucin Binding Reduces Colistin Antimicrobial Activity.
Topics: Acinetobacter baumannii; Animals; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Culture Media; Daptomycin; Dialysis; Dialysis Solutions; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mucins; Polymyxin B; Protein Binding; Pseudomonas aeruginosa; Staphylococcus aureus; Swine; Tobramycin | 2015 |
Eosinophilic pneumonia: Daptomycin-induced lung complication.
Topics: Abscess; Amputation Stumps; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Combined Modality Therapy; Daptomycin; Debridement; Diabetic Foot; Drainage; Drug Substitution; Drug Therapy, Combination; Humans; Male; Middle Aged; Pulmonary Eosinophilia; Soft Tissue Infections; Surgical Wound Infection; Tomography, X-Ray Computed | 2016 |
Antibiofilm Activity and Synergistic Inhibition of Staphylococcus aureus Biofilms by Bactericidal Protein P128 in Combination with Antibiotics.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Daptomycin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gentamicins; Linezolid; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Recombinant Fusion Proteins; Staphylococcus aureus; Vancomycin | 2016 |
Tuning of the Lethal Response to Multiple Stressors with a Single-Site Mutation during Clinical Infection by
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Cross Infection; Daptomycin; Gene Expression Regulation, Bacterial; Genome, Bacterial; Humans; Mutation; Quorum Sensing; Staphylococcal Infections; Staphylococcus aureus; Stress, Physiological; Trans-Activators; Virulence | 2017 |
Liquid chromatography-tandem mass spectrometry for the quantification of moxifloxacin, ciprofloxacin, daptomycin, caspofungin, and isavuconazole in human plasma.
Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Chromatography, High Pressure Liquid; Ciprofloxacin; Daptomycin; Echinocandins; Fluoroquinolones; Humans; Limit of Detection; Lipopeptides; Moxifloxacin; Nitriles; Plasma; Pyridines; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazoles | 2018 |
Simultaneous quantification of plasma levels of 12 antimicrobial agents including carbapenem, anti-methicillin-resistant Staphylococcus aureus agent, quinolone and azole used in intensive care unit using UHPLC-MS/MS method.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Azoles; Carbapenems; Chromatography, High Pressure Liquid; Ciprofloxacin; Daptomycin; Doripenem; Drug Monitoring; Female; Fluconazole; Fluoroquinolones; Humans; Intensive Care Units; Levofloxacin; Linezolid; Male; Meropenem; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazines; Oxazolidinones; Quinolones; Tandem Mass Spectrometry; Tetrazoles; Voriconazole | 2021 |
Antimicrobial Photodynamic Inactivation Affects the Antibiotic Susceptibility of
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Combined Modality Therapy; Daptomycin; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Microbial Sensitivity Tests; Photochemotherapy; Photosensitizing Agents; Plankton | 2021 |